BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 17389513)

  • 1. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.
    Colombo ES; Menicucci G; McGuire PG; Das A
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1793-800. PubMed ID: 17389513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
    Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target.
    McGuire PG; Jones TR; Talarico N; Warren E; Das A
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2736-42. PubMed ID: 12766081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and neuroprotective effect of hepatocyte growth factor in retinal ischemia-reperfusion injury.
    Shibuki H; Katai N; Kuroiwa S; Kurokawa T; Arai J; Matsumoto K; Nakamura T; Yoshimura N
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):528-36. PubMed ID: 11818401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
    Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
    Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
    Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
    Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
    Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
    Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor exerts multiple biological functions on bovine mammary epithelial cells.
    Accornero P; Martignani E; Macchi E; Baratta M
    J Dairy Sci; 2007 Sep; 90(9):4289-96. PubMed ID: 17699048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAP kinase and beta-catenin signaling in HGF induced RPE migration.
    Liou GI; Matragoon S; Samuel S; Behzadian MA; Tsai NT; Gu X; Roon P; Hunt DM; Hunt RC; Caldwell RB; Marcus DM
    Mol Vis; 2002 Dec; 8():483-93. PubMed ID: 12500177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis.
    Nagashima M; Hasegawa J; Kato K; Yamazaki J; Nishigai K; Ishiwata T; Asano G; Yoshino S
    J Rheumatol; 2001 Aug; 28(8):1772-8. PubMed ID: 11508578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells.
    Kuba K; Matsumoto K; Ohnishi K; Shiratsuchi T; Tanaka M; Nakamura T
    Biochem Biophys Res Commun; 2000 Dec; 279(3):846-52. PubMed ID: 11162438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages.
    Camussi G; Montrucchio G; Lupia E; Soldi R; Comoglio PM; Bussolino F
    J Immunol; 1997 Feb; 158(3):1302-9. PubMed ID: 9013973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines.
    Lasagna N; Fantappiè O; Solazzo M; Morbidelli L; Marchetti S; Cipriani G; Ziche M; Mazzanti R
    Cancer Res; 2006 Mar; 66(5):2673-82. PubMed ID: 16510587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.
    Jiang WG; Hiscox SE; Parr C; Martin TA; Matsumoto K; Nakamura T; Mansel RE
    Clin Cancer Res; 1999 Nov; 5(11):3695-703. PubMed ID: 10589789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor is essential for migration of myogenic cells and promotes their proliferation during the early periods of tongue morphogenesis in mouse embryos.
    Amano O; Yamane A; Shimada M; Koshimizu U; Nakamura T; Iseki S
    Dev Dyn; 2002 Mar; 223(2):169-79. PubMed ID: 11836782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor expression in the developing myocardium: evidence for a role in the regulation of the mesenchymal cell phenotype and urokinase expression.
    Song W; Majka SM; McGuire PG
    Dev Dyn; 1999 Jan; 214(1):92-100. PubMed ID: 9915579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.
    Saito Y; Nakagami H; Morishita R; Takami Y; Kikuchi Y; Hayashi H; Nishikawa T; Tamai K; Azuma N; Sasajima T; Kaneda Y
    Circulation; 2006 Sep; 114(11):1177-84. PubMed ID: 16952986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.